$20.365
0.345[1.72%]
Last update: 11:42AM Get Real Time Here
Intellia Therapeutics
(NASDAQ:NTLA)Intellia Therapeutics Stock (NASDAQ:NTLA), Earnings Estimates, EPS, and Revenue
Intellia Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 10
EPS Estimate
$-1.380
Quarterly Revenue Estimate
$11.5M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$36.3M
Analyze the earnings history of Intellia Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/10/2024 | AM | NTLA | Q1 | -$1.17 | -$1.38 | — | — | $12.61M | $11.50M | — | — | Get Alert |
| 02/22/2024 | AM | NTLA | Q4 | -$1.40 | -$1.45 | -$1.46 | -0.69% | $13.57M | — | -$1.92M | — | Get Alert |
| 11/09/2023 | AM | NTLA | Q3 | -$1.49 | -$1.50 | -$1.38 | 8.00% | $13.27M | $12.45M | $11.99M | -3.68% | Get Alert |
| 08/03/2023 | AM | NTLA | Q2 | -$1.33 | -$1.32 | -$1.40 | -6.06% | $14.03M | $13.95M | $13.59M | -2.55% | Get Alert |
| 05/04/2023 | AM | NTLA | Q1 | -$1.96 | -$1.40 | -$1.17 | 16.43% | $11.25M | $11.83M | $12.61M | 6.56% | Get Alert |
| 02/23/2023 | AM | NTLA | Q4 | -$1.09 | -$1.39 | -$1.40 | -0.72% | $12.85M | $11.33M | $13.57M | 19.80% | Get Alert |
| 11/03/2022 | AM | NTLA | Q3 | -$0.97 | -$1.28 | -$1.49 | -16.41% | $7.20M | $11.31M | $13.27M | 17.29% | Get Alert |
| 08/04/2022 | AM | NTLA | Q2 | -$1.01 | -$1.31 | -$1.33 | -1.53% | $6.55M | $9.42M | $14.03M | 48.94% | Get Alert |
| 05/05/2022 | AM | NTLA | Q1 | -$0.69 | -$1.10 | -$1.96 | -78.18% | $6.45M | $8.54M | $11.25M | 31.76% | Get Alert |
| 02/24/2022 | AM | NTLA | Q4 | -$0.69 | -$0.94 | -$1.09 | -15.96% | $6.59M | $8.26M | $12.85M | 55.62% | Get Alert |
| 11/04/2021 | AM | NTLA | Q3 | -$0.47 | -$0.84 | -$0.97 | -15.48% | $22.22M | $8.66M | $7.20M | -16.81% | Get Alert |
| 08/05/2021 | AM | NTLA | Q2 | -$0.61 | -$0.63 | -$1.01 | -60.32% | $16.26M | $11.89M | $6.55M | -44.91% | Get Alert |
| 05/06/2021 | AM | NTLA | Q1 | -$0.63 | -$0.67 | -$0.69 | -2.99% | $12.92M | $8.57M | $6.45M | -24.80% | Get Alert |
| 02/25/2021 | AM | NTLA | Q4 | -$0.57 | -$0.60 | -$0.69 | -15.00% | $10.94M | $14.09M | $6.59M | -53.19% | Get Alert |
| 11/05/2020 | AM | NTLA | Q3 | -$0.49 | -$0.59 | -$0.47 | 20.34% | $10.62M | $15.58M | $22.22M | 42.62% | Get Alert |
| 08/06/2020 | AM | NTLA | Q2 | -$0.56 | -$0.69 | -$0.61 | 11.59% | $11.12M | $8.54M | $16.26M | 90.43% | Get Alert |
| 05/07/2020 | AM | NTLA | Q1 | -$0.49 | -$0.44 | -$0.63 | -43.18% | $10.43M | $18.14M | $12.92M | -28.80% | Get Alert |
| 02/27/2020 | AM | NTLA | Q4 | -$0.43 | -$0.56 | -$0.57 | -1.79% | $7.88M | $9.94M | $10.94M | 10.02% | Get Alert |
| 10/31/2019 | AM | NTLA | Q3 | -$0.53 | — | -$0.49 | — | $7.41M | — | $10.62M | — | Get Alert |
FAQ
When is Intellia Therapeutics (NASDAQ:NTLA) reporting earnings?
Intellia Therapeutics (NTLA) is scheduled to report earnings on May 10, 2024. The last reported earnings were for reported on February 22, 2024 for Q4.
What were the latest earnings per share (EPS) for Intellia Therapeutics (NASDAQ:NTLA)?
The Actual EPS was $-1.46, which missed the estimate of $-1.45.
What were Intellia Therapeutics’s (NASDAQ:NTLA) revenues?
The Actual Revenue was $-1.9M, which missed the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.